Skip to main content
. 2022 Apr 20;14:100390. doi: 10.1016/j.onehlt.2022.100390

Fig. 6.

Fig. 6

The pooled prevalence of multidrug-resistant (MDR) S. agalactae in humans was 0.51(0.12–0.89), I2 = 92.83%, and p = 0.